BBIO (BRIDGEBIO PHARMA INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 9 institutional investors hold BBIO (BRIDGEBIO PHARMA INC) with a combined value of $2.43B across 96,176,317 shares. The largest holder is BlackRock, Inc. with a position worth $1.11B (0.02% of their portfolio). Bridgewater Associates, LP opened a new position in the most recent quarter. 7 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$2.43B
Total Shares Held
96,176,317
Institutional Holders
9
Recent Activity
Bridgewater Associates, LPNew Position
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.11B | 0.02% | +1.0% |
| 2 | VIKING GLOBAL INVESTORS LP | $1.10B | 2.92% | -9.9% |
| 3 | CITADEL ADVISORS LLC | $96.15M | 0.01% | +210.5% |
| 4 | CITADEL ADVISORS LLC | $83.99M | 0.01% | +53.4% |
| 5 | BlackRock, Inc. | $13.15M | 0.00% | +32.3% |
| 6 | BlackRock, Inc. | $10.61M | 0.00% | +32.2% |
| 7 | CITADEL ADVISORS LLC | $5.63M | 0.00% | +0.0% |
| 8 | Bridgewater Associates, LP | $3.30M | 0.01% | New |
| 9 | Point72 Asset Management, L.P. | $581.32K | 0.00% | +0.0% |
Track BBIO institutional moves
Get notified when hedge funds change their BBIO positions.